Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SY-005 in Sepsis Subjects
NCT04898322Phase 2Unknown
- Sponsor
- Yabao Pharmaceutical Group Co., Ltd.
- Start
- Jan 2022
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of annexin a5 in sepsis, sponsored by Yabao Pharmaceutical Group Co., Ltd.. Status: unknown.
02
Drugs
annexin a5
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT04898322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04898322.